RTW INVESTMENTS, LP - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 142 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$183,173,899
+19.1%
5,286,404
-0.5%
2.84%
+24.9%
Q1 2024$153,777,820
+26.2%
5,315,5140.0%2.27%
+19.2%
Q4 2023$121,884,736
+34.9%
5,315,514
-1.8%
1.90%
-0.1%
Q3 2023$90,330,774
-39.6%
5,415,5140.0%1.91%
-33.1%
Q2 2023$149,576,497
+41.4%
5,415,514
+17.7%
2.85%
+29.2%
Q1 2023$105,818,377
+170.0%
4,600,799
+28.1%
2.20%
+175.5%
Q4 2022$39,188,567
+11.3%
3,591,986
-14.0%
0.80%
-1.5%
Q3 2022$35,211,000
-7.2%
4,176,837
-12.9%
0.81%
-17.1%
Q2 2022$37,924,000
-66.6%
4,794,4990.0%0.98%
-58.3%
Q1 2022$113,534,000
+27.7%
4,794,499
+84.4%
2.35%
+81.0%
Q4 2021$88,914,000
+186.1%
2,599,822
+48.2%
1.30%
+176.8%
Q3 2021$31,075,000
-80.3%
1,753,695
-50.0%
0.47%
-80.3%
Q2 2021$157,412,000
+73.3%
3,507,3900.0%2.38%
+67.5%
Q1 2021$90,841,000
+23.5%
3,507,390
-3.9%
1.42%
+14.8%
Q4 2020$73,585,000
+10.4%
3,650,069
+7.1%
1.24%
-23.1%
Q3 2020$66,645,000
+11.5%
3,408,961
+0.8%
1.60%
-4.5%
Q2 2020$59,747,000
+218.1%
3,383,208
+27.2%
1.68%
+108.0%
Q1 2020$18,782,000
+8.3%
2,660,392
+8.1%
0.81%
+23.5%
Q4 2019$17,343,000
+89.4%
2,459,988
+222.7%
0.65%
+20.2%
Q3 2019$9,155,000762,2830.54%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Johnson & Johnson Innovation - JJDC, Inc. 2,449,183$43,253,0008.50%
BVF INC/IL 2,367,288$41,806,0002.58%
RTW INVESTMENTS, LP 3,383,208$59,747,0001.68%
Novo Holdings A/S 824,169$14,555,0000.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,013,495$17,898,0000.52%
Sofinnova Investments, Inc. 326,064$5,758,0000.36%
FARALLON CAPITAL MANAGEMENT LLC 2,500,000$44,150,0000.35%
Virtus ETF Advisers LLC 21,639$382,0000.18%
Baker Brothers Advisors 1,911,446$33,756,0000.15%
King Wealth Management Group 22,000$389,0000.11%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders